PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 18, 2009Proceedings of the National Academy of Sciences294 citationsOpen Access

Transmission dynamics and economics of rabies control in dogs and humans in an African city

View Full Paper
JZJakob ZinsstagSDSalome DürrMPMelissa A. Penny

Key Points

Key points are not available for this paper at this time.

Abstract

Human rabies in developing countries can be prevented through interventions directed at dogs. Potential cost-savings for the public health sector of interventions aimed at animal-host reservoirs should be assessed. Available deterministic models of rabies transmission between dogs were extended to include dog-to-human rabies transmission. Model parameters were fitted to routine weekly rabid-dog and exposed-human cases reported in N'Djaména, the capital of Chad. The estimated transmission rates between dogs (beta (d) ) were 0. 0807 km2/ (dogs x week) and between dogs and humans (beta (dh) ) 0. 0002 km2/ (dogs x week). The effective reproductive ratio (R (e) ) at the onset of our observations was estimated at 1. 01, indicating low-level endemic stability of rabies transmission. Human rabies incidence depended critically on dog-related transmission parameters. We simulated the effects of mass dog vaccination and the culling of a percentage of the dog population on human rabies incidence. A single parenteral dog rabies-mass vaccination campaign achieving a coverage of least 70% appears to be sufficient to interrupt transmission of rabies to humans for at least 6 years. The cost-effectiveness of mass dog vaccination was compared to postexposure prophylaxis (PEP), which is the current practice in Chad. PEP does not reduce future human exposure. Its cost-effectiveness is estimated at US 46 per disability adjusted life-years averted. Cost-effectiveness for PEP, together with a dog-vaccination campaign, breaks even with cost-effectiveness of PEP alone after almost 5 years. Beyond a time-frame of 7 years, it appears to be more cost-effective to combine parenteral dog-vaccination campaigns with human PEP compared to human PEP alone.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zinsstag et al. (2009) studied this question.

synapsesocial.com/papers/6a225738316ec316da7c954chttps://doi.org/10.1073/pnas.0904740106
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cost‐description of a pilot parenteral vaccination campaign against rabies in dogs in N'Djaména, Chad2006 · 69 citations
  2. 2Owner Valuation of Rabies Vaccination of Dogs, Chad2008 · 41 citations
  3. 3Rabies Diagnosis for Developing Countries2008 · 118 citations
  4. 4Laboratory Techniques in Rabies1997 · 511 citations
  5. 5Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions2005 · 56 citations